Pharmaron Biologics

San Diego, CA · Shaoxing, CN
AAV Lentiviral Plasmid
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-02
85.6
Signal Score
✓ FDA Inspections (3) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Pharmaron Biologics

Signal Score
85.6/100 (as of 2026-04-02)
Quality Compliance
100.0/100 — Bonus: 3 consecutive NAI inspections
Headquarters
San Diego, CA · Shaoxing, CN
Modalities
AAV, Lentiviral, Plasmid
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance 100.0
Bonus: 3 consecutive NAI inspections
Source: FDA Data Dashboard
Bonus: 3 consecutive NAI inspections
FDA Inspections3 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-07-17)
Bonus: 3 consecutive NAI inspections
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 83.0
Publicly traded — financial transparency
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
Capacity 63.0
2 manufacturing sites
Sites: San Diego, CA, Shaoxing, China
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
2 manufacturing sites

FDA Inspection History

2025-07
2025-01
2024-09
NAI VAI OAI
Date Site Type Observations Classification
2025-07-17 Coventry, Rhode Island Drug Quality Assurance No No Action Indicated (NAI)
2025-01-17 Exton, Pennsylvania Human Cellular, Tissue, and Gene Therapies No No Action Indicated (NAI)
2024-09-27 Exton, Pennsylvania Bioresearch Monitoring No No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Plasmid CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Catalent (Novo Holdings)
Harmans, MD · Gosselies, BE
Signal Score: 79.7
AAV, CAR-T, Lentiviral, Plasmid
uBriGene Biosciences
Shanghai, CN · Boston, MA
Signal Score: 60.5
AAV, Lentiviral, Plasmid
Yposkesi (SK Pharmteco)
Corbeil-Essonnes, FR
Signal Score: 80.3
AAV, Lentiviral, Plasmid